CARD 7 antibody; CARD7 antibody; Caspase recruitment domain protein 7 antibody; Caspase recruitment domain-containing protein 7 antibody; CLR17.1 antibody; Death effector filament forming Ced 4 like apoptosis protein antibody; Death effector filament-forming ced-4-like apoptosis protein antibody; DEFCAP antibody; DEFCAP L/S antibody; DKFZp586O1822 antibody; KIAA0926 antibody; LRR and PYD domains-containing protein 1 antibody; NAC alpha/beta/gamma/delta antibody; NAC antibody; NACHT antibody; NACHT leucine rich repeat and PYD containing 1 antibody; NACHT leucine rich repeat and PYD pyrin domain containing 1 antibody; NACHT leucine rich repeat and pyrin domain containing 1 antibody; NACHT LRR and PYD containing protein 1 antibody; NALP 1 antibody; NALP1 antibody; NALP1_HUMAN antibody; NLR family pyrin domain containing 1 antibody; NLRP 1 antibody; NLRP1 antibody; NLRP1 protein antibody; Nucleotide binding domain and caspase recruitment domain antibody; Nucleotide binding oligomerization domain leucine rich repeat and pyrin domain containing 1 antibody; Nucleotide-binding domain and caspase recruitment domain antibody; PP 1044 antibody; PP1044 antibody
Description:
The antibody against NLRP1 was raised in rabbit using the Human NLRP1 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, IHC.